Osteoclast activation is initiated by adhesion to the bone surface, followed by cytoskeletal rearrangement, the formation of the sealing zone, and a polarized ruffled membrane. This study shows that PYK2/CAK ␤ /RAFTK, a cytoplasmic kinase related to the focal adhesion kinase, is highly expressed in rat osteoclasts in vivo. Using murine osteoclastlike cells ( 
Introduction
Integrins are cell surface receptors that mediate cell-extracellular matrix (ECM) 1 and cell-cell interactions and the initiation of signals that control many cell functions (1, 2) . The cytoplasmic focal adhesion kinase (FAK) has been implicated in integrin signaling, which includes changes in intracellular Ca 2 ϩ , lipid turnover, and tyrosine phosphorylation and leads to cytoskeletal rearrangements and gene expression (3) (4) (5) .
PYK2/CAK ␤ /RAFTK is a member of the focal adhesion kinase family (3) (4) (5) . PYK2 and FAK are 65% homologous; both lack a transmembrane region, SH2 or SH3 domains, but have proline-rich regions in the C terminus. PYK2 is expressed in neuronal and hemopoietic cells, including megakaryocytes and various lymphocytic and myeloid cell lines (5, 6) , which also express FAK. PYK2 was suggested to play a different role than FAK (7) (8) (9) (10) (11) . In megakaryocytes and B cells, PYK2 is tyrosine phosphorylated in an integrin-dependent manner and localizes to "focal adhesion-like structures" (12, 13) . In vitro, PYK2 binds to the protein tyrosine kinases Src and Fyn, as well as to p130 cas , paxillin, and Grb-2 (3, 7, (12) (13) (14) (15) . Recently, PYK2 and Src were reported to play a role in the signaling pathways that link G-protein-coupled receptors with mitogenactivated protein kinase (7) .
Osteoclasts are the bone-resorbing cells and play a key role in bone remodeling (16) . Osteoclast adhesion to the bone surface induces cytoskeletal reorganization and cell activation (17) . The recognition of extracellular matrix components possibly mediated by ␣ v ␤ 3 is thought to initiate osteoclast function (18, 19) . In vitro integrin-mediated adhesion to vitronectin, fibronectin, or collagen induces osteoclast spreading and actin rearrangement (20) . In addition, signaling pathways, which involve c-Src, c-Cbl, or PI3-kinase, were shown to be important for osteoclastic bone resorption (21) (22) (23) (24) .
The object of this study was to examine a possible role for PYK2 in osteoclast activation. We show that PYK2 is highly expressed in osteoclasts in vivo and in osteoclast-like cells (OCLs) in culture. Tyrosine phosphorylation of PYK2 is induced upon attachment to vitronectin, osteopontin, and fibronectin and is mediated by ␤ 3 integrins. PYK2 is found in the sealing zone, and its phosphorylation correlates with the formation of the sealing zone and with OCL bone resorption. In addition, in OCLs, PYK2 associates with c-Src in an SH2-dependent manner. Furthermore, in the resorption-deficient Src ( Ϫ / Ϫ ) OCLs, PYK2 is not tyrosine phosphorylated. These findings suggest that PYK2 may play a role in Src-dependent intracellular pathways that link ␤ 3 -integrin mediated osteoclast adhesion to osteoclast activation and the formation of the osteoclast sealing zone on the bone surface.
Biotech (Santa Cruz, CA). Anti-␤ 2 integrin (mAb 18/2) antibody was from ATCC (Rockville, MD), anti-␤ 1 (mAb 9EG7) and anti-␤ 3 (mAb 2C9.G2) integrins were from PharMingen (San Diego, CA), and F(ab) Ј 2 of anti-rat or -hamster IgG, FITC-and TRITC-conjugated IgG were from Jackson Labs (West Grove, PA). HRP-secondary antibodies were from Amersham (Arlington Heights, IL); collagenase and dispase were from Wako, Inc. (Dallas, TX). Tissue culture reagents were from GIBCO BRL (Grand Island, NY). 1 ␣ ,25-(OH) 2 D 3 (D 3 ) was a gift from Dr. M. Uskokovich, HoffmannLaRoche (Nutley, NJ). Recombinant c-Src was from Upstate Biotech, glutathione-S-transferase (GST) fusion proteins of Fyn, Lyn, and PI3-kinase were from PharMingen and Santa Cruz. GST-fusion proteins of c-Src and PYK2 were generated by PCR using oligonucleotides flanking the indicated domains, cloned into the pGEX-4T plasmid (Pharmacia Biotech, Piscataway, NJ), and expressed according to manufacturer.
Isolation of osteoclast-like cells and of prefusion osteoclast-like cells. Bone marrow-derived OCLs were prepared as previously described (25) . Osteoblastic MB1.8 cells were cocultured with murine bone marrow cells in ␣ -MEM containing 10% FBS and 10 nM D 3 . After 7 d, the cocultures were washed in PBS and treated with collagenase/dispase (each at 0.01% [wt/vol] in PBS) at 37 Њ C for 20 min. After MB1.8 cells were removed, lysates of attached OCLs were prepared as described below. The prefusion osteoclast-like cells (pOCs) were isolated from the cocultures as described (25) with the use of 10 mM EDTA in Ca 2 ϩ /Mg 2 ϩ -free PBS to lift pOCs. Purity of the preparations was 85-95%, and the cells obtained in this manner have the same properties as pOCs isolated using the previous method. Bone resorption activity was determined by plating MB1.8 cells (pretreated with D 3 for 48 h) on bovine cortical bone slices and then adding pOCs for the indicated times. Cells were then either solubilized and immunoprecipitated or immunostained as described below. The resorption pits were determined as described (25) .
Heterozygous Src ( ϩ / Ϫ ) mice were obtained from Jackson Labs (Bar Harbor, ME) and mated to generate osteopetrotic Src ( Ϫ / Ϫ ) mice, which were identified by the lack of tooth eruption. OCLs were prepared from spleen cells isolated from 3-wk-old Src ( Ϫ / Ϫ ) mice and their normal Src ( ϩ /?) littermates as described (24) .
RNA isolation and Northern blot analysis. Total cellular RNA was isolated as described (26) . A specific probe for PYK2 (570 bp) was generated by PCR using the primers: 5 Ј -(AGTGACATTTA-TCAGATGGAG) and 3 Ј -(GAATGGACTGTGCACCGAGCC), with OCL-derived cDNAs as template. A probe for FAK (700 bp) was generated according to the published sequences, using the primers: 5 Ј -(CAGCACACAATCCTGGAGGAG) and 3 Ј -(GCTGAAG-CTTGACACCTCAT) with cDNAs of MB1.8 cells as template (5, 27) .
Attachment of pOCs to ECM. Polystyrene dishes (Becton Dickinson, Lincoln Park, NJ) were coated at 4 Њ C for 15 h with either FBS or 25 g/ml human fibronectin (NY Blood Center, New York) or 10 g/ml human vitronectin or 50 g/ml recombinant osteopontin or 25 g/ml mouse laminin (GIBCO BRL) or 25 g/ml collagen type I or IV (Collaborative Biomed, Bedford, MA). Before cell attachment, pOCs (3 ϫ 10 5 cells/ml) were washed (2 ϫ ) with serum-free ␣ -MEM medium and 0.1% BSA and then either kept in suspension or allowed to attach to ECM-coated plates for the indicated times at 37 Њ C. Cells were solubilized in modified RIPA buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.2% sodium deoxycholate, 1 mM EDTA, 10 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM PMSF, 10 g/ml aprotinin and 10 g/ml leupeptin) on ice for 20 min and prepared for immunoprecipitation.
Integrin clustering Antibody-induced integrin clustering was performed as reported (28) . Cell suspensions (3 ϫ 10 5 cells/ml) were incubated with anti-␤ 1 , anti-␤ 2 or anti-␤ 3 antibodies at 25 g/ml, 4 Њ C for 1 h. Cells were washed with ice-cold serum-free medium (2 ϫ ) with 100 mM vanadate and resuspended in medium containing 50 g/ml of goat F(ab) Ј 2 anti-rat IgG or anti-hamster IgG, followed by incubation at 37 Њ C for 30 min. Cells were lysed in modified RIPA buffer and subjected to immunoprecipitation and -blotting as described below.
Translocation into the cytoskeletal fraction. Translocation of PYK2 into the cytoskeletal fraction was measured as described (29) . pOCs were cultured with or without MB1.8 cells at equal cell density (3.0 ϫ 10 5 cells) on plastic tissue culture plates or bone for 2 h at 37 Њ C. Cells were washed gently with ice-cold PBS with 1 mM vanadate, then extracted in 0.5% Triton X-100, 10 mM Tris-HCl, pH 7.4, including phosphatase and protease inhibitors, for 5 min on ice. The soluble fractions were collected, and the insoluble fractions were then solubilized in RIPA buffer. Both were immunoblotted using anti-PYK2 antibodies. The levels of PYK2 were quantitated using an Imaging Densitometer (Model GS-700; BioRad, Hercules, CA) and expressed as percentage of total PYK2 protein in both fractions combined.
Immunoprecipitation. Cell lysates in RIPA buffer were immunoprecipitated using anti-PYK2 antibodies (2 g) for 2 h, followed by protein G-sepharose (Pharmacia) for 1 h at 4 Њ C. After washing with RIPA (4 ϫ ), proteins were separated on SDS-PAGE (12% gels; Novex, San Diego, CA) and blotted onto Immobilon-P transfer membranes (Millipore, Bedford, MA). Phosphotyrosine and PYK2 protein were estimated by immunoblotting either with HRP-conjugated antiphosphotyrosine mAb 4G10 or with anti-PYK2 antibodies, followed by HRP-anti-rabbit IgG. Blots were developed by enhanced chemiluminescence (ECL; Amersham) at different exposure times for quantitation. Imaging densitometry was used to estimate the specific activity of tyrosine phosphorylated PYK2, which was quantitated as the ratio of phosphorylated PYK2 to its protein content, and expressed relative to controls (cells in suspension).
In vitro protein association assays. OCL lysates (1 mg/ml) were in TNE buffer and incubated with 10 g of GST-fusion protein coupled with glutathione-sepharose beads for 2 h at 4 Њ C. The beads were washed with lysis buffer (4 ϫ ) and with PBS (1 ϫ ), then subjected to immunoblot analysis using anti-PYK2 antibodies. For coimmunoprecipitation, pOCs (2.5 ϫ 10 6 cells) were solubilized in TNE lysis buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM EDTA, 10% glycerol, with phosphatase and protease inhibitors). Clarified cell lysates were incubated with anti-PYK2 N-terminal domain or anti-Src antibodies and sequentially blotted with anti-Src and anti-PYK2 antibodies, as described above.
Kinase assay. pOCs were plated on plastic or bone surfaces with or without MB1.8 cells (3 ϫ 10 5 cells/ml). Cells were washed in PBS and solubilized in TNE buffer at the indicated times. In assays using inhibitors, cocultures were plated on bone slices for 4 h, then treated with cytochalasin D (5 M) or calcitonin (100 nM) for 20 min or with echistatin (1 M) for 1 h. PYK2 was immunoprecipitated from the clarified lysates. Half of the immunoprecipitates were subjected to blotting with antiphosphotyrosine or anti-PYK2 antibodies, and the other half was washed with kinase assay buffer (20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 10 mM MnCl 2 and 1 mM dithiothreitol), followed by the addition of 5 Ci [ ␥ -32 P] ATP (3,000 Ci/mmol, Amersham) and 1 M cold ATP, incubated for 10 min at 30 Њ C. The reaction was subjected to SDS-PAGE and autoradiography. Specific activity of 32 P-labeled PYK2 was quantitated as described above.
Phosphorylation of PYK2 by the recombinant c-Src was performed as described by the manufacturer (Upstate Biotech). Lysates of Src ( ϩ /?) and Src ( Ϫ / Ϫ ) OCLs (800 g/ml) were immunoprecipitated with anti-N-PYK2 antibodies and washed with RIPA buffer (5 ϫ ) and kinase buffer (1 ϫ ). Each precipitate was equally divided and incubated with [ ␥ - Immunofluorescence staining and confocal microscopy. Immunofluorescent labeling of podosomes and sealing zone structures in OCLs was performed as described (17) . PYK2 was visualized using anti-PYK2 antibodies, followed by TRITC anti-rabbit IgG. Actin was stained with 500 mU/ml FITC-phalloidin (Molecular Probes, Inc., Eugene, OR). Cells on glass coverslips were photographed using a Zeiss Axiophot epifluorescence microscope, and cells on bone slices were viewed with a confocal laser scanning microscope consisting of a Wild Aristophan fluorescent microscope and Leica Lasertechnik GmbH 1.05 software (Heidelberg, Germany) (19) .
Immunoperoxidase staining of tissue sections. Tibiae were dissected from Sprague Dawley female rats (6 mo old) and fixed in 4% paraformaldehyde (in PBS) for 24 h, then demineralized in 20% EDTA, 10% formalin for 6 wk, and embedded in paraffin. Deparaffinized sections (10 m) were permeabilized with 0.1% Triton X-100, PBS, and incubated with 2% BSA and then with 0.5% hydrogen peroxide (30 min each at 25ЊC). The slides were washed in 0.1% Triton X-100, PBS (3ϫ, 10 min each). This was repeated after each subsequent step. Sections were incubated with anti-PYK2 polyclonal antibodies (10 g/ml), incubated with HRP-conjugated second antibody, and developed with diaminobenzidine. All sections were counterstained with methyl green.
Results
Expression of PYK2 in osteoclasts in vitro and in vivo. PYK2 expression was not detected in MB1.8 cells but was readily detected in the coculture with bone marrow, even in the absence of D 3 treatment, probably due to the presence of PYK2 in hemopoietic cells (Fig. 1 A) . With D 3 treatment, PYK2 expression increased approximately twofold and was further enriched ‫ف(‬ 16-fold) in the purified OCL fraction ( Fig. 1 A) . In contrast, the osteoblastic MB1.8 cells appear to be the major source of FAK in the coculture. In OCLs, FAK expression was barely detected. These findings suggest that in the coculture system PYK2 expression is abundant in osteoclasts.
PYK2 protein expression examined by Western blot analysis ( Fig. 1 B) was not detected in MB1.8 cells. Similar levels of PYK2 were found in purified pOCs, cultured with or without MB1.8 cells, indicating that PYK2 is primarily derived from OCLs in this system. The size of PYK2 is ‫ف‬ 110 kD, but several lower molecular weight bands (75 kD, 80 kD, and 97 kD) were seen, possibly due to proteolytic degradation. Similar calpain-dependent degradation products of PYK2 were reported in platelets stimulated with thrombin (10) .
Abundant expression of PYK2 was also observed in vivo in osteoclasts attached to bone using immunohistochemistry (Fig.  2) . PYK2 was also detected in megakaryocytes and small cells in the bone marrow, which could be lymphocytes or platelets (Fig. 2) . PYK2 was not detected in other cells, including osteoblasts. In control sections, when the primary antibody was omitted, no staining was observed (data not shown).
Ligation of ␤ 3 integrin increases PYK2 tyrosine phosphorylation in prefusion osteoclast-like cells. Since mature osteoclasts are isolated based on tight adherence to tissue culture plates and cannot be detached undamaged by conventional methods, pOCs provide the opportunity to examine the effect of adhesion on PYK2 tyrosine phosphorylation. These cells are isolated in high purity (85-95%) and express the cellular markers found in multinucleated OCLs, such as tartrate resistant acid phosphatase, calcitonin receptors, cathepsin K, and most importantly ␣ v ␤ 3 integrin (25) . When pOCs maintained in suspension are allowed to attach for 1 h to plates coated either with serum or with various ECM proteins, there is a marked increase in PYK2 tyrosine phosphorylation (Fig. 3 A) . Largest effects were seen with vitronectin or osteopontin, less with serum, fibronectin, or denatured type I collagen but not type IV collagen or laminin. Phosphorylation increased during 1 h following plating on vitronectin (Fig. 3 B) , a time course that parallels OCLs spreading and formation of actin-rich adhesion structures on bone surfaces (25, 30) .
The vitronectin receptor ␣ v ␤ 3 is the most abundant integrin in osteoclasts (31) , while the fibronectin receptor ␣ v ␤ 1 and the laminin/collagen receptor ␣ 2 ␤ 1 are present at a lower level (32, 33). The role of these integrins in adhesion-induced tyrosine phosphorylation of PYK2 was therefore examined. pOCs were incubated with either anti-␤ 1 , anti-␤ 2 , or anti-␤ 3 monoclonal antibodies followed by secondary antibodies, to enhance clustering. Ligation of the ␤ 3 integrin increases PYK2 tyrosine phosphorylation, while ligation of the ␤ 1 or ␤ 2 integrins does not (Fig. 3 C) .
c-Src binds to PYK2 in osteoclast-like cells via the SH2 domain. Since integrin-mediated tyrosine phosphorylation of FAK recruits c-Src (34, 35) and c-Src plays a role in the organization of the osteoclast cytoskeleton (24), we examined a possible role for c-Src in PYK2 phosphorylation in osteoclasts. In lysates prepared from adherent OCLs, PYK2 is constitutively tyrosine phosphorylated (see Fig. 5 B ) and coimmunoprecipitates with c-Src, using either antibodies against the N-terminal domain of PYK2 or anti-c-Src (Fig. 4 A ) . In addition, using GST-fusion proteins, we found that PYK2 binds to Src-SH2 domain but not Src-SH3 (Fig. 4 B ) . Interestingly, PYK2 isolated from adherent OCLs did not bind to the SH2 domains of other Src family kinases (Fyn and Lyn) or of PI3 kinase, suggesting selective interaction of PYK2 with the Src-SH2 domain.
Tyrosine phosphorylation and kinase activity of PYK2 are reduced in Src ( ϪրϪ ) OCLs, and PYK2 is a substrate of exogeneous c-Src. Since in Src ( Ϫ / Ϫ ) mice, osteoclast function is severely compromised, we examined the state of tyrosine phosphorylation and activation of PYK2 in OCLs from Src ( Ϫ / Ϫ ) mice. Tyrosine phosphorylation of several proteins ‫ف‬ 100-120 kD and 50-60 kD is markedly reduced in Src ( Ϫ / Ϫ ) OCLs compared with Src ( ϩ /?) (Fig. 5 A ) . In the same blots, PYK2 levels in Src ( Ϫ / Ϫ ) OCLs were comparable with those in Src ( ϩ /?). The absence of c-Src in Src ( Ϫ / Ϫ ) OCLs is also documented (Fig. 5, A and C ). Most importantly, the level of tyrosine phosphorylation of PYK2 in Src ( Ϫ / Ϫ ) OCLs is markedly reduced (Fig. 5 B ) compared with OCLs from normal littermates. Similarly, the level of 32 P-phosphorylation associated with PYK2 immunoprecipitated from Src ( Ϫ / Ϫ ) OCLs is also significantly reduced (Fig. 5 C ) . In the same preparation, the level of tyrosine phosphorylation of paxillin (Fig. 5 B ) , an adhesion-dependent cytoskeletal protein, was not altered.
Furthermore, PYK2 is directly phosphorylated by exogeneous c-Src (Fig. 5 D ) . To reduce the level of associated endogeneous proteins, PYK2 immunoprecipitated from OCL cell lysates, were extensively washed with RIPA buffer before addition of exogeneous c-Src. In PYK2 immunoprecipitated from Src ( ϩ /?) OCLs, there is some 32 P-incorporation possibly due to autophosphorylation or to a small amount of associated endogeneous kinases. There is no detectable 32 P-incorporated into PYK2 immunoprecipitated from Src ( Ϫ / Ϫ ) OCLs. However, in the presence of exogeneous Src, PYK2 is highly phosphorylated, whether derived from control cells or Src ( Ϫ / Ϫ ) OCLs, indicating that PYK2 can be a direct substrate of c-Src in OCLs.
Adhesion-induced translocation of PYK2 into the cytoskeletal fraction. Since the sealing zone formed upon osteoclast adhesion is very rich in actin filaments, we examined the partition of PYK2 between the cytoskeletal (Triton insoluble) and cytoplasmic (Triton soluble) compartments in pOCs adhering 5 cells/ml) were either kept in suspension (Susp.) or allowed to adhere for 1 h to dishes coated with either serum, vitronectin (VN, 10 g/ml), osteopontin (OPN, 50 g/ml), fibronectin (FN, 25 g/ml), collagen type I (Col I, 25 g/ml), collagen type IV (Col IV, 25 g/ml), or laminin (LN, 25 g/ml). (B) pOCs were allowed to attach to dishes coated with VN for the indicated times at 37ЊC. (C) pOCs were in suspension (susp.) or incubated with anti-␤ 1 , anti-␤ 2 , or anti-␤ 3 integrin at 25 g/ml for 1 h at 4ЊC, followed by secondary antibodies (50 g/ml) for 30 min at 37ЊC. Cell lysates were immunoprecipitated and blotted as described in Methods.
to plastic or bone surfaces in the absence or presence of MB1.8 cells. In the absence of MB1.8 cells, PYK2 was in the soluble (noncytoskeletal) fraction and attachment of pOCs did not cause PYK2 translocation into the Triton-insoluble fraction (Fig. 6, top) . In suspended pOCs in the presence of MB1.8 cells, a small portion of PYK2 (10%) was found in the cytoskeletal Triton-insoluble fraction (Fig. 6, lane 2) . However, on plastic or bone surfaces, in the presence of MB1.8 cells about a third of PYK2 redistributed to the Triton-insoluble fraction, 24% (lane 4) and 34% (lane 6) of total PYK2, respectively (Fig. 6, bottom) . Tyrosine phosphorylation of PYK2 in the Triton-soluble and insoluble fractions were not significantly different, as determined by Western blotting with antiphosphotyrosine antibodies (data not shown). In vitro kinase assays of PYK2 could not be performed in the Triton-insoluble fractions because of the presence of SDS in the extraction buffer.
Adhesion-dependent activation of PYK2 kinase in OCLs is enhanced by the osteoblastic MB1.8 cells. We and others reported that osteoblastic cells support the fusion of pOCs and are necessary for the resorption of mineralized matrix by OCLs (25) . As shown in Fig. 7 A, MB1.8 cells had no significant effect on PYK2 tyrosine phosphorylation in pOCs seeded either on plastic (relative specific activities 3.9 with MB1.8 cells vs. 4.1 without) or bone (4.3 vs. 3.2). However, in vitro kinase activities measured by 32 P-incorporation into PYK2 (immunoprecipitated in the presence of orthovanadate), were approximately twofold higher in pOCs plated with MB1.8 cells (Fig. 7 B) , suggesting that the interaction of pOCs with MB1.8 cells, while not detectably affecting the level of tyrosine phosphorylation in PYK2, might increase its kinase activity. The kinase activities measured under these conditions include PYK2 autophosphorylation as well as the activity of other kinases coimmunoprecipitated with PYK2.
Activation of PYK2 kinase parallels the formation of the sealing zone and bone resorption activity. Findings reported above suggest the involvement of PYK2 in the cytoskeletal reorganization associated with OCL fusion and bone resorption. We therefore examined kinase activity in PYK2 immunoprecipitated from lysates of pOCs cocultured with MB1.8 cells plated on bone and actively resorbing bone for 1, 2, 4, 8 or 21 h (Fig. 8 A) . Resorption pits were counted in the same bone slices (Fig. 8 B) . In parallel cocultures stained with phalloidin, F-actin containing sealing zone structures were also counted (Fig. 8 B) . As shown, there was a sustained increase in the specific activity of in vitro kinase activity associated with the PYK2 immunocomplexes (Fig. 8 A) that paralleled the formation of sealing zones and of resorption pits (Fig. 8 B) . In addition, a number of phosphorylated proteins were coimmunoprecipitated with PYK2, including detectable bands of ‫ف‬ 250 kD, 68-70 kD, and 40-50 kD. The total level of PYK2 protein was significantly reduced at 21 h, along with reduction in total protein in cell lysates at that time. The same observation was made in three repeated experiments. Although the reason for this apparent reduction in extracted protein is not known, it may be due to degradation of PYK2 in activated osteoclasts, as observed in thrombin-activated platelets (10) or tighter association of cytoskeletal proteins with the bone surface and reduced extractibility under the mild solubilization conditions required for the immunoprecipitation and in vitro kinase assays.
Treatment with echistatin, cytochalasin D, or calcitonin inhibits PYK2 kinase activity. The above observations suggested a relationship between PYK2 kinase activity and the organization of the osteoclastic cytoskeleton. We therefore examined the effect of agents known to disrupt osteoclastic cytoskeletal organization, such as cytochalasin D, echistatin, or calcitonin on PYK2 activity in OCLs (36, 37) . pOCs were cocultured with MB1.8 cells on bone slices for 4 h, the time required for the formation of actin ring structures in OCLs on glass coverslips and the formation of sealing zones on bone (Fig. 8 B) . Subsequent treatment of the cocultures with cytochalasin D for 20 min inhibited PYK2 kinase activity by 61%, suggesting that cytoskeletal association played a role in kinase activity. Treatment with inhibitors of bone resorption, echistatin for 1 h or calcitonin for 20 min, resulted in 38 and 27% inhibition in PYK2 kinase activity, respectively (Fig. 8 C) .
Localization of PYK2 in the actin-rich ring-like adhesion structures in osteoclast-like cells.
To complement above biochemical findings, we examined microscopically the presence of PYK2 in the actin rings of multinucleated OCLs, the formation of which is promoted in pOCs by coculture with D 3 -treated MB1.8 cells. In pOCs plated on glass coverslips for 1 h Figure 4 . c-Src binds to PYK2 via the SH2 domain. (A) Co-immunoprecipitation of PYK2 and c-Src from OCLs. Lysates (1 mg/ml) prepared from purified OCLs were immunoprecipitated either with anti-N-PYK2 (2 g/ml) or with anti-Src antibodies (2 g/ml). Precipitates were washed and separated on 12% SDS-PAGE and blotted with either anti-PYK2 or anti-Src antibodies. ECL film development for the coprecipitated proteins was 10 min and for the immuno-precipitated proteins was 0.5-1 min. (B) OCL lysates (1 mg/ml) were incubated with 10 g of GST or of GST fusion proteins containing SH2 and SH3 domains of the indicated kinases, for 3 h at 4ЊC, washed and separated on SDS-PAGE, and then blotted with anti-PYK2 antibodies.
in the presence of MB1.8 cells, F-actin is localized in discrete dots or podosomes and in the forming rings of a spreading osteoclast (Fig. 9 b) . This contrasts with the localization of F-actin in stress fibers, observed in the neighboring MB1.8 cells (in green, Fig. 9 b) . PYK2 localization shown in red is similar to that of actin in podosomes and in the cell body (compare Fig.  9, a and b) . Colocalization of the two proteins appears in yellow (Fig. 9 c) . Note the complete absence of PYK2 in MB1.8 cells. After plating (4 h), pOCs fuse to form large, spread, multinucleated cells (OCLs) with F-actin organized in ring-like structures around the cellular periphery, shown in green (Fig. 9  e) . In these cells, PYK2 also reorganizes and localizes in these rings (in red, Fig. 9 d) . Perinuclear localization of PYK2 is also detected. Colocalization of PYK2 and F-actin is seen in yellow 5 cells each. Cells were in suspension (susp.) or plated on plastic or bone slices for 2 h at 37ЊC, then fractionated as described in Methods. Triton-soluble (TS) and insoluble fractions (TIS) were blotted with anti-PYK2 antibodies. In cocultures of pOCs and MB1.8, PYK2 in the TIS fraction relative to the PYK2 protein in both fractions, was 10% in susp., 24% on plastic, and 34% on bone.
in the overlapping image (Fig. 9 f) . In these OCL ring structures, PYK2 also colocalizes with the cytoskeletal proteins vinculin and paxillin (data not shown).
PYK2 localization in the sealing zone of osteoclast-like cells on bone surfaces. The actin-rich ring-like structures formed in
OCLs in vitro are thought to be related to the tight sealing zones formed by osteoclasts on bone matrix during polarization before bone resorption. In resorbing OCLs on bone (Fig.  10) , PYK2 (in red) was concentrated in the sealing zone and colocalized with F-actin (in green) in the ring-like structure and possibly in the ruffled border within the ring (Fig. 10, a-c) . PYK2 was found in the double circle structure of the mature sealing zone, which colocalizes with vinculin and paxillin (data not shown). In addition, confocal microscopic optical sections through the sealing zone showed PYK2 staining in the whole sealing zone and also distributed in the cytoplasm where colocalization with F-actin is not observed (red, Fig. 10, d-f) .
In Src (Ϫ/Ϫ) OCLs, PYK2 is diffusely localized in the cytoplasm and focal-adhesion-like contacts. Since PYK2 was not tyrosine phosphorylated in Src (Ϫ/Ϫ) OCLs, we examined the localization of PYK2 in these cells. In contrast to the typical ring-like adhesion contacts found in OCLs derived from the normal mice (Fig. 11, d-f ), podosomes and ring-like structures were completely absent in Src (Ϫ/Ϫ) OCLs (Fig. 11, a-c) . Instead, there were small focal adhesion-like structures underneath the nucleus and around the cell periphery, visualized by F-actin localization shown in green (Fig. 11 b) . In Src (Ϫ/Ϫ) OCLs, PYK2 in red was distributed throughout the cytoplasm and was also localized to these small focal adhesion contacts (Fig. 11 a) . Overlapped localization of PYK2 and F-actin is shown in yellow (Fig. 11 c) .
Discussion
The main findings of this study are that in osteoclasts, PYK2 is an adhesion kinase that is tyrosine phosphorylated in a c-Srcdependent manner upon ligand engagement or ligation of the ␣ v ␤ 3 integrin and is activated by osteoclast interaction with osteoblastic (MB1.8) cells. Furthermore, PYK2 localizes to the sealing zone of resorbing osteoclasts, along with F-actin, vinculin, and paxillin, suggesting that it plays a role in the attachment-dependent cytoskeletal reorganization required for osteoclast activity.
PYK2 is highly expressed in osteoclasts in vivo and osteoclast-like cells generated in cocultures of murine bone marrow and osteoblastic MB1.8 cells. The adhesion-dependent kinase FAK was previously reported to be present in osteoclasts (38) . However, in this study, we found that FAK is highly expressed in osteoblastic MB1.8 cells and in primary calvaria osteoblasts (data not shown) but was only barely detectable in osteoclasts. In contrast, PYK2 appears to be the predominant adhesiondependent kinase present in osteoclasts, as demonstrated by Northern analysis, Western blots, and immunostaining methods. With the same methods, expression of PYK2 was undetectable in the osteoblastic MB1.8 cells. We could therefore conclude that PYK2 phosphorylation and activation in the cocultures of MB1.8 cells and purified pOCs reflected PYK2 changes in osteoclasts.
Osteoclastic bone resorption is a multistep process that starts with matrix recognition, osteoclast attachment, polariza- tion, and formation of the actin-rich sealing zone on the bone surface. Osteoclasts express at least three integrins: the vitronectin receptor ␣ v ␤ 3 , the collagen receptor ␣ 2 ␤ 1 , and the fibronectin receptor ␣ v ␤ 1 (39) . ␣ v ␤ 3 ligands were shown to inhibit bone resorption, suggesting that its function is rate limiting for osteoclast activity (19, 37) . The tyrosine phosphorylation of PYK2 in pOCs upon adhesion to known substrates of ␣ v ␤ 3 or the ligation of ␤ 3 integrins suggests that PYK2 may play a role in the function of ␣ v ␤ 3 in osteoclasts. The increase in tyrosine phosphorylation of PYK2 in pOCs correlated with the spreading of OCLs and the formation of actin rings on substrate-coated surfaces, which normally required at least 1 h (25, 30) . This is in contrast to the faster (20 min) tyrosine phosphorylation of PYK2 in macrophages (our unpublished observation) or of FAK in fibroblasts (27) . Tyrosine phosphorylation of PYK2 also has been reported in megakaryocytes and T-lymphocytes upon attachment to fibronectin and upon ligation of ␤ 1 and ␤ 3 integrins, respectively (5, 40) .
To further examine the possible role of PYK2 in osteoclast function, we used OCLs obtained from cocultures of MB1.8 cells and Src (Ϫ/Ϫ)-derived spleen cells. Targeted disruption of c-Src in mice causes osteopetrosis. These mice have a normal number of osteoclasts, which attach to bone, but lack ruffled borders (21, 22) . Src (Ϫ/Ϫ) OCLs obtained in cocultures have focal adhesion-like contacts underneath the nucleus and sometimes around the periphery of the cell but do not display the normal adhesion contacts seen in the Src (ϩ/?) OCLs. Even in the presence of normal primary osteoblasts or MB1.8 cells, Src (Ϫ/Ϫ) OCLs never organize the dot-like adhesion contacts into ring-like structures, which are thought to preceed the formation of sealing zones on bone surfaces (17) . In normal adhering OCLs, c-Src is phosphorylated and stably associated with PYK2. In Src (Ϫ/Ϫ) OCLs, PYK2 tyrosine phosphorylation and its kinase activity was markedly reduced. In addition, PYK2 immunoprecipitated from Src (Ϫ/Ϫ) OCLs was shown to be a direct substrate of c-Src in vitro, suggesting that the adhesion-dependent tyrosine phosphorylation of PYK2 is mediated by c-Src in osteoclasts in vivo. Furthermore, in Src (Ϫ/Ϫ) OCLs, PYK2 does not localize to actin-rich adhesion structures, suggesting that Src-kinase activity and PYK2 phosphorylation may be needed for the recruitment of other molecules involved in the organization of the sealing zone in osteoclasts.
Other evidence that supports PYK2 interaction with Src is that overexpression of PYK2 in human embryonic kidney 293T cells stimulates the endogenous Src activity in these cells (10) . In addition, PYK2 tyrosine phosphorylation depends, in part, on Src kinase activity and is stimulated by Src binding to the autophosphorylated site Tyr402 on PYK2 (7). Our observation that PYK2 binds GST-Src-SH2 domain is consistent with these reports. Notably, no binding to the SH2 domain in Fyn, Lyn, or PI3 kinase was seen. Interestingly, overexpression of activated Src (Y527F) in PC12 cells induced tyrosine phosphorylation of PYK2 but did not stimulate PYK2 kinase activity (7). Consistent with the findings reported here, PYK2 phosphorylation mediated by Src may generate docking sites for additional signaling proteins that are recruited by PYK2 (7) .
Integrin stimulation in fibroblasts induces the activation and redistribution of c-Src to focal contact structures (41) . Furthermore, enhanced FAK tyrosine phosphorylation and stable association between Src and FAK were detected in Src-transformed cells (42) , whereas FAK tyrosine phosphorylation is reduced in fibroblasts isolated from Src (Ϫ/Ϫ) mice (43) , pointing to several similarities between FAK and PYK2 in fibroblasts and osteoclasts, respectively. The protooncogene product c-Cbl was also found to be tyrosine phosphorylated in a Src-dependent manner in osteoclasts and was suggested to act downstream of c-Src in a signaling pathway that is required for bone resorption (24) . The relationship between PYK2 and c-Cbl in osteoclasts requires further study.
Additional insights into the role of PYK2 in the cytoskeletal organization important for osteoclast function is provided by the effects of osteoblasts. The presence of osteoblasts promotes survival, fusion, and formation of multinucleated OCLs that resorb bone (25, 44) . In this system, pOCs do not survive and do not resorb bone without vitamin D 3 -treated MB1.8 cells. Indeed, on bone, the presence of these cells was necessary for the activation of OCLs including the formation of F-actin rings and of resorption pits (25) . In addition, in the absence of MB1.8 cells, pOCs adhere via podosomes but cannot organize sealing zones on bone surfaces (data not shown). In this study, interaction with MB1.8 cells increased the PYK2 kinase activity, which rose in parallel with the formation of actin rings, associated with osteoclast activation, and with the excavation of resorption pits. In the presence of MB1.8 cells, podosomal adhesion structures in pOCs organize into sealing zones, suggesting a role for PYK2 in the dynamic organization of the actin-rich sealing zone structures. This is supported by the prominent localization of PYK2 in the actin ring of OCLs on glass and in the sealing zone of osteoclasts on bone. Furthermore, disruption of microfilament organization by treatment of OCLs with cytochalasin D rapidly reduced PYK2 kinase activity. We also examined the effects of echistatin and calcitonin, two known inhibitors of osteoclast function. Both, echistatin, a RGD-containing ligand of the ␣ v ␤ 3 integrin, and calcitonin, a physiological ligand of a G-protein-linked receptor (36, 37) , reduced PYK2 kinase activity to some extent. These findings support a relationship between PYK2 activity, cytoskeletal organization, and osteoclast function.
During bone resorption, several other phosphorylated proteins in addition to c-Src could associate with PYK2 in OCLs. The C-terminal domain of PYK2 contains several functional sites that are conserved in FAK, including two different proline-rich binding regions for p130
cas (crk associated substrate) and Graf (GTPase regulator associated with FAK), a binding region for paxillin and an overlapping sequence for focal targeting (45) . An association of PYK2 and p130
cas was demonstrated in B lymphocytes (13) , and p130
cas was reported to localize to the actin-rich ring-like structures in OCLs (46) . In megakaryocytes, phorbol myristate acetate treatment resulted in tyrosine phosphorylation of PYK2 and induced the association of PYK2 and paxillin, a 68-kD cytoskeletal protein (15) . In resorbing OCLs on bone, paxillin colocalizes with PYK2 in the sealing zone, suggesting possible interaction between these two proteins.
In conclusion, although many questions remain to be answered regarding the role of PYK2 in osteoclast activation, in vitro and in vivo evidence presented in this study strongly sug- gests that PYK2 is a major cell adhesion-dependent kinase in osteoclasts. PYK2 localizes to the podosome-containing ringlike adhesion structures in OCLs on plastic and to the sealing zone on bone. In OCLs, PYK2 was found to associate tightly with Src via its SH2 domain. In addition, in OCLs from Src (Ϫ/Ϫ) mice, tyrosine phosphorylation and kinase activity of PYK2 was greatly reduced. Taken together these data suggest that ligand binding to ␣ v ␤ 3 on the osteoclast surface leads to Src-dependent tyrosine phosphorylation of PYK2. Furthermore, osteoblast-dependent effects enhance PYK2 association with the actin cytoskeleton and increase the kinase activity of PYK2 and its associated proteins, leading to the formation of the actin-rich sealing zone. There are certainly many molecules involved in this process, but PYK2 seems to play a major role as an adhesion kinase that participates in the initial events of osteoclast activation.
